Filing Details

Accession Number:
0001209191-18-011308
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-02-20 16:18:30
Reporting Period:
2018-02-15
Accepted Time:
2018-02-20 16:18:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
742112 Invacare Corp IVC Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) 952680965
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1236982 Martin C Harris One Invacare Way
Elyria OH 44035
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Disposition 2018-02-15 3,443 $18.15 34,315 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Shares Stock Option (Right to Buy) $0.00 6,919 6,919 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
6,919 6,919 Direct
Footnotes
  1. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $18.125 - $18.178. The reporting person hereby undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  2. Includes 12,860 previously reported restricted stock units issued pursuant to the Invacare Corporation 2013 Equity Compensation Plan. 4,254 of these restricted stock units vest in full on May 15, 2018 after a three-year "cliff" vesting period and 8,606 of these restricted stock units vest in full on May 15, 2018.
  3. No transaction is being reported on this line. Reported on a previously filed Form 3, Form 4, or Form 5.
  4. The reporting person holds previously reported options to buy 6,919 Common Shares (with tandem tax withholding rights) under the Invacare Corporation 2003 Performance Plan, granted in reliance upon the exemption provided by Rule 16b-3. These options were granted on August 20, 2008, at an exercise price of $25.79 per share, will expire August 20, 2018, and became exercisable between September 30, 2009 and September 30, 2012.
  5. The current balance reflects the expiration of 5,650 options on August 22, 2017.